Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001085463.2(CTNND1):c.-57T>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
CTNND1 (HGNC:2515): (catenin delta 1) This gene encodes a member of the Armadillo protein family, which function in adhesion between cells and signal transduction. Multiple translation initiation codons and alternative splicing result in many different isoforms being translated. Not all of the full-length natures of the described transcript variants have been determined. Read-through transcription also exists between this gene and the neighboring upstream thioredoxin-related transmembrane protein 2 (TMX2) gene. [provided by RefSeq, Dec 2010]
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Sep 26, 2024
The c.247T>A (p.L83M) alteration is located in exon 4 (coding exon 2) of the CTNND1 gene. This alteration results from a T to A substitution at nucleotide position 247, causing the leucine (L) at amino acid position 83 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of methylation at K79 (P = 0.0665);Gain of methylation at K79 (P = 0.0665);Gain of methylation at K79 (P = 0.0665);.;Gain of methylation at K79 (P = 0.0665);Gain of methylation at K79 (P = 0.0665);Gain of methylation at K79 (P = 0.0665);Gain of methylation at K79 (P = 0.0665);.;.;.;Gain of methylation at K79 (P = 0.0665);.;.;.;.;Gain of methylation at K79 (P = 0.0665);.;